MeVis Medical Solutions AG's ROE % for the quarter that ended in Mar. 2026 was 6.98%. MeVis Medical Solutions AG's PB Ratio for the quarter that ended in Mar. 2026 was 2.25.
MeVis Medical Solutions AG's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 3.10%.
MeVis Medical Solutions AG ROE % Adjusted to Book Value Related Terms
MeVis Medical Solutions AG ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for MeVis Medical Solutions AG's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MeVis Medical Solutions AG ROE % Adjusted to Book Value Chart
FRA:M3V vs VEEV, BTSG, TEM: ROE % Adjusted to Book Value Comparison
For the Health Information Services subindustry, MeVis Medical Solutions AG's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MeVis Medical Solutions AG ROE % Adjusted to Book Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MeVis Medical Solutions AG's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where MeVis Medical Solutions AG's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of 3.10% mean?
MeVis Medical Solutions AG (FRA:M3V) has a ROE % Adjusted to Book Value of 3.10% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on MeVis Medical Solutions AG and its competitors.
Is MeVis Medical Solutions AG's ROE % Adjusted to Book Value too high?
MeVis Medical Solutions AG's current ROE % Adjusted to Book Value is 3.10%. Overall, MeVis Medical Solutions AG has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does MeVis Medical Solutions AG's ROE % Adjusted to Book Value compare to VEEV and BTSG?
MeVis Medical Solutions AG's ROE % Adjusted to Book Value of 3.10% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Providers & Services company?
A good ROE % Adjusted to Book Value depends on the Healthcare Providers & Services industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on MeVis Medical Solutions AG and its competitors. MeVis Medical Solutions AG's current ROE % Adjusted to Book Value is 3.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MeVis Medical Solutions AG stock overvalued right now?
MeVis Medical Solutions AG (FRA:M3V) has a current ROE % Adjusted to Book Value of 3.10%. The stock's GF Value™ is €22.52, compared to a current price of €24.00 — trading 6.6% above its estimated fair value. The current ROE % Adjusted to Book Value is 3.10%. MeVis Medical Solutions AG's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For MeVis Medical Solutions AG (FRA:M3V), the current ROE % Adjusted to Book Value is 3.10% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MeVis Medical Solutions AG (FRA:M3V) Overvalued in 2026?
Based on GuruFocus' analysis, MeVis Medical Solutions AG stock appears to be overvalued.
The current stock price of €24.00 is trading 6.6% above its estimated GF Value™ of €22.52.
Key valuation signals for FRA:M3V:
ROE % Adjusted to Book Value: 3.10%
GF Value™: €22.52 vs. price of €24.00 (6.6% above fair value)
No single metric tells the full story. See the FRA:M3V stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.
66GF Score
Get the complete analysis for FRA:M3V
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:M3V has been successfully added to your 
